Xiao 2009.
Study characteristics | ||
Methods | Randomized controlled trial conducted at Schenzen Maternity and Child Healthcare Hospital from March 2004 through September 2007. | |
Participants | Term infants born in Schenzen, China to healthy mothers with no history of hepatitis B or liver dysfunction, infants weighing ≥ 2 kg with Apgar 7–10 with no obvious abnormalities. Monitored from day 3 to 6–7 of life. | |
Interventions | Randomized to 1 of 4 groups: sunlight, bath, sunlight + bath, or neither sunlight nor bath (control) Sunlight
Bath
|
|
Outcomes |
|
|
Notes | Jaundice definitions and management criteria: serum bilirubin level 257–291 µmol/L indicated diagnosis of jaundice. Value > 291 µmol/L required hospital admission. Normal serum bilirubin 205–257 µmol/L. Funding source not provided. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Information not reported in study. |
Allocation concealment (selection bias) | Unclear risk | Information not reported in study. |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Study did not comment on blinding. |
Blinding of outcome assessment (detection bias) All outcomes | High risk | Study did not comment on blinding. |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Authors did not comment on data completion/loss to follow‐up. |
Selective reporting (reporting bias) | Unclear risk | Trial registration not identified. |
Other bias | Unclear risk | None identified. |
AAP: American Academy of Pediatrics; BW: birthweight; CPT: conventional phototherapy; FSPT: filtered‐sunlight phototherapy; GA: gestational age; IEPT: intensive electric phototherapy; PT: phototherapy; TCB: transcutaneous bilirubin; TSB: total serum bilirubin.